FDAnews Drug Daily Bulletin

Devising strategies to engage physicians, teaching hospitals and medical societies will be critical to implementing a successful Sunshine Act compliance program, healthcare compliance expert Michaeline Daboul says. The Centers for Medicare & Medicaid Services is sparing drug and device manufacturers and group purchasing organizations from reporting payments made to doctors and hospitals in 2012 because it must still release the final rule; however, data collection is expected to begin in January 2013.
Clinical Trials Advisor